An Intervention to Reduce Sedentary Behavior for Adults With Chronic Kidney Disease
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- The protocol lists: RESET-CKD, Attention Control.
- Who it may be relevant to
- Registry conditions: Chronic Kidney Disease(CKD). Basic parameters: 35 years — 80 years · All.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- United States
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Official title
An Intervention to Reduce Sedentary Behavior for Adults With Chronic Kidney Disease: RESET-CKD
Overview
RESET-CKD is evaluating an intervention to support Black adults with chronic kidney disease (CKD) to reduce their sedentary (e.g., sitting) time. Half of the participants will be randomized to the intervention, where the goal is to support individuals to reduce their sitting time, and the other half will be randomized to an attention control condition that provides CKD-related education not related to sedentary behavior. All participants will be followed for 12 weeks.
Interventions
- Behavioral RESET-CKD
RESET-CKD is a 12-week intervention that consists of four major components to support decreasing sedentary behavior: (1) health coaching, (2) feedback charts on sedentary behavior, (3) a workbook, and (4) reminders and cues. - Other Attention Control
CKD-related education
Primary outcome measures
- Change in sedentary time [Time frame: Baseline to week 12]
Secondary outcome measures (2)
- Change in self-reported sedentary time [Time frame: Baseline to week 12]
- Change in health-related quality of life [Time frame: Baseline to week 12]
Eligibility criteria
Inclusion criteria
- Self-identifies as Black or African American
- Age ≥35 to ≤80 years old
- CKD Stage 1-4
- Self-reported 6 or more hours/day of sedentary time
- Ability to speak/read/understand English
- Has access to a telephone
Exclusion criteria
- Being unable to walk 1 block
- Being unable to stand from a seated position without assistance
- Using a wheelchair, walker, or cane for all of their ambulation
- Presence of a condition(s) or diagnosis, either physical or psychological, that precludes participation, including: Lower-extremity amputation (AKA or BKA) without prosthetic, Orthopedic condition that would preclude prompted sit-to-stand transitions or standing, Neurologic or psychiatric condition that would preclude prompted sit-to- stand transitions or standing, Severe cognitive impairment, Unstable coronary artery disease (i.e., angina with activity), Orthostatic hypotension
- Kidney transplant
- Any other condition that the investigator considers precludes participation in the trial
- Participated in the Patient Advisory Board
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Healthy volunteers: No
Study design
- Allocation
- Randomized
- Model
- Parallel assignment
- Masking
- Open label
- Primary purpose
- Other
Study locations
United States · 1 center
- UI Health/University of Illinois Chicago — Chicago
Identifiers
NCT: NCT06754280 · 2024-1410 · K23NR021034